Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Gulilat

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Cold Spring Harbor Perspectives in Medicine|May 31, 2018
The Role of Next-Generation Sequencing in Pharmacogenetics and PharmacogenomicsUte I Schwarz, Markus Gulilat, Richard B Kim
CJC Open|January 24, 2022
Association of Sex With Stroke and Bleeding Risk of Apixaban and Rivaroxaban in Elderly Atrial Fibrillation Patients Using Propensity Score WeightsMarkus Gulilat, Racquel Jandoc, Nivethika Jeyakumar, et al.
CJEM|September 3, 2023
Pain management in adult patients with sickle cell disease in the emergency department: how does current practice compare with existing standards of care?Markus Gulilat, Lanre Tunji-Ajayi, Serena Thompson, et al.
Journal of the American Geriatrics Society|May 22, 2019
Apixaban Concentrations with Lower than Recommended Dosing in Older Adults with Atrial FibrillationSmrithi Sukumar, Markus Gulilat, Bradley Linton, et al.
Journal of Thrombosis and Thrombolysis|September 30, 2019
Drug interactions and pharmacogenetic factors contribute to variation in apixaban concentration in atrial fibrillation patients in routine careMarkus Gulilat, Denise Keller, Bradley Linton, et al.
BMC Medical Genomics|June 5, 2019
Targeted next generation sequencing as a tool for precision medicineMarkus Gulilat, Tyler Lamb, Wendy A Teft, et al.
The Canadian Journal of Cardiology|July 30, 2017
Interpatient Variation in Rivaroxaban and Apixaban Plasma Concentrations in Routine CareMarkus Gulilat, Anthony Tang, Steven E Gryn, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Cold Spring Harbor Perspectives in Medicine|May 31, 2018
The Role of Next-Generation Sequencing in Pharmacogenetics and PharmacogenomicsUte I Schwarz, Markus Gulilat, Richard B Kim
CJC Open|January 24, 2022
Association of Sex With Stroke and Bleeding Risk of Apixaban and Rivaroxaban in Elderly Atrial Fibrillation Patients Using Propensity Score WeightsMarkus Gulilat, Racquel Jandoc, Nivethika Jeyakumar, et al.
CJEM|September 3, 2023
Pain management in adult patients with sickle cell disease in the emergency department: how does current practice compare with existing standards of care?Markus Gulilat, Lanre Tunji-Ajayi, Serena Thompson, et al.
Journal of the American Geriatrics Society|May 22, 2019
Apixaban Concentrations with Lower than Recommended Dosing in Older Adults with Atrial FibrillationSmrithi Sukumar, Markus Gulilat, Bradley Linton, et al.
Journal of Thrombosis and Thrombolysis|September 30, 2019
Drug interactions and pharmacogenetic factors contribute to variation in apixaban concentration in atrial fibrillation patients in routine careMarkus Gulilat, Denise Keller, Bradley Linton, et al.
BMC Medical Genomics|June 5, 2019
Targeted next generation sequencing as a tool for precision medicineMarkus Gulilat, Tyler Lamb, Wendy A Teft, et al.
The Canadian Journal of Cardiology|July 30, 2017
Interpatient Variation in Rivaroxaban and Apixaban Plasma Concentrations in Routine CareMarkus Gulilat, Anthony Tang, Steven E Gryn, et al.
Pageof 1